z-logo
open-access-imgOpen Access
Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum–Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial
Author(s) -
Goshi Nishimura,
Hiromitsu Hatakeyama,
Osamu Shiono,
Masataka Taguri,
Masanori Komatsu,
Daisuke Sano,
Naoko Sakuma,
Kenichiro Yabuki,
Yasuhiro Arai,
Kunihiko Shibata,
Yoshihiro Chiba,
Teruhiko Tanabe,
Nobuhiko Oridate
Publication year - 2018
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/11003
Subject(s) - cetuximab , medicine , docetaxel , head and neck cancer , oncology , chemoradiotherapy , clinical trial , protocol (science) , head and neck , radiation therapy , cancer , surgery , pathology , colorectal cancer , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom